Skip to main content

and
  1. No Access

    Article

    Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies

    Ramucirumab is a novel antiangiogenic agent approved as second-line therapy for patients with advanced stomach cancer and gastroesophageal junction adenocarcinoma. Although existing evidence from clinical tria...

    Jianhua Wang, Zexing Wang, Yunzhao Zhao in Clinical Drug Investigation (2015)

  2. No Access

    Article

    Lipopolysaccharide-Induced Bacterial Translocation Is Intestine Site-Specific and Associates with Intestinal Mucosal Inflammation

    The present study aimed to determine whether any specific intestinal site or intestinal mucosal inflammation is highly correlated with bacterial translocation (BT). Enterostomy tubes were surgically placed in ...

    Chao Yue, Bingqiang Ma, Yunzhao Zhao, Qiurong Li, Jieshou Li in Inflammation (2012)